Skip to content

Effect of oxycodone with parecoxib sodium on postoperative analgesia in patients undergoing hip arthroplasty

Effect of oxycodone with parecoxib sodium on postoperative analgesia in patients undergoing hip arthroplasty

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071934
Enrollment
Unknown
Registered
2023-05-30
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Parecoxib group:Precoxib sodium was injected before surgery
Oxycodone group:Oxycodone injection was injected before surgery
Oxycodone injection+Parecoxib sodium group:Before surgery, oxycodone and parecoxib sodium were injected
Control group:NS injection was injected before surgery

Sponsors

The Second People's Hospital of Changzhou City, Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Patients who met the diagnostic criteria for hip fracture and were confirmed with THA by imaging examination have no previous history of hip fracture or related diseases; 2: American Association of Anesthesiologists (ASA) I -III 3: Age is between 19-90 years 4: Volunteer to participate in the trial and provide the patient's signed informed consent form 5: No analgesics have been used within 1 week before surgery 6: Non-steroidal anti-inflammatory drugs were not taken for 3d before the surgery

Exclusion criteria

Exclusion criteria: ? Patients with severe cardiopulmonary disease (ASA>III) who need to be transferred to ICU for further treatment; ? Patients with a history of chronic opioid abuse; ? Patients with allergy to experimental drugs and metabolites; ? Fractures of other parts; ? Combined with serious heart, lung, brain, liver, kidney and other systemic serious diseases.

Design outcomes

Primary

MeasureTime frame
VAS(visual analogue scale);

Secondary

MeasureTime frame
NRS(numerical rating scal);5-Hydroxytryptamine;

Countries

China

Contacts

Public ContactYunHuifang

The Second People's Hospital of Changzhou City, Jiangsu Province

yhfdoctor68778@njmu.edu.cn+86 138 1356 8778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026